69 related articles for article (PubMed ID: 1794294)
1. In vitro and in vivo antibacterial activities of ME1220 and ME1221, novel cephalosporins.
Okamoto R; Tamura A; Yoshida T; Komiya I; Ogino H; Inouye S; Kondo S; Inoue M; Mitsuhashi S
Drugs Exp Clin Res; 1991; 17(4):205-12. PubMed ID: 1794294
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain.
Orikasa Y; Hara T; Miyata A; Tamura A; Kawaharajo K; Matsumoto T; Komiya I; Iwamatsu K; Shibahara S; Inouye S
J Antimicrob Chemother; 1991 Jan; 27(1):41-53. PubMed ID: 2050596
[TBL] [Abstract][Full Text] [Related]
3. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Bakhtiar M; Selwyn S
Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
Mitsukude M; Inoue M; Mitsuhashi S
Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
[TBL] [Abstract][Full Text] [Related]
6. [Specificities of antibacterial activity of zwitterionic 7-methoxyimino cephems (cephalosporins of fourth generation].
Pechère JC
Pathol Biol (Paris); 1996 Feb; 44(2):99-105. PubMed ID: 8761594
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
[TBL] [Abstract][Full Text] [Related]
8. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
9. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
10. In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
Choi KH; Kim DJ; Shim JS; Choi MJ; Park NJ; Kim BO; Yu YH; Choi EC
J Antimicrob Chemother; 1994 Jun; 33(6):1233-7. PubMed ID: 7646611
[No Abstract] [Full Text] [Related]
11. Influence of protein binding on the pharmacodynamics of ceftazidime or ceftriaxone against gram-positive and gram-negative bacteria in an in vitro infection model.
Scaglione F; Demartini G; Arcidiacono MM; Dugnani S; Fraschini F
J Chemother; 1998 Feb; 10(1):29-34. PubMed ID: 9531073
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
14. Novel cephalosporin derivatives possessing a bicyclic heterocycle at the 3-position. Part II: Synthesis and antibacterial activity of 3-(5-methylthiazolo[4,5-c]pyridinium-2-yl)-thiomethylcephalosporin derivatives and related compounds.
Tsushima M; Kano Y; Umemura E; Iwamatsu K; Tamura A; Shibahara S
Bioorg Med Chem; 1998 Sep; 6(9):1641-53. PubMed ID: 9801835
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Abd-Elalim Eltahawy AT; Khalaf RM
Chemioterapia; 1988 Apr; 7(2):75-8. PubMed ID: 3293818
[TBL] [Abstract][Full Text] [Related]
16. [Activity of cefpirome against bacteria isolated from hospitalized patients].
Fernández A; Herran I; de Mier C; Marcenac FM
Medicina (B Aires); 1989; 49(4):373-8. PubMed ID: 2487748
[TBL] [Abstract][Full Text] [Related]
17. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
Bell JM; Turnidge JD;
Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological properties of some 3-[(N-substituted-amino)pyridinium-4-thiomethyl]-7-[2-(2-amino-thiazol- 4-yl)-2-(Z)-(methoxyimino)acetamido]ceph-3-em-4-carboxylates.
Branch CL; Adams RG; Brain EG; Guest AW; Harrington FP; Knott SJ; Pearson MJ; Zomaya II
J Antibiot (Tokyo); 1993 Aug; 46(8):1289-99. PubMed ID: 8407591
[TBL] [Abstract][Full Text] [Related]
19. Orally active cephalosporins. IV. Synthesis, antibacterial activity and oral absorption of 3-(1H-1,2,3-triazol-4-yl)thiomethylthio-cephalosporins.
Kume M; Kubota T; Kimura Y; Nakashimizu H; Motokawa K
Chem Pharm Bull (Tokyo); 1993 Apr; 41(4):758-62. PubMed ID: 8508477
[TBL] [Abstract][Full Text] [Related]
20. Studies on beta-lactam antibiotics. IV. An improved synthesis of 3-(isothiazolylthiomethyl)cephalosporins and its application to new derivatives.
Hara R; Nakai E; Hisamichi H; Nagano N
J Antibiot (Tokyo); 1994 Apr; 47(4):477-86. PubMed ID: 8195048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
